approval
saveTRAVOPROST — FDA approval
community read0 votes
Sponsor: ALEMBIC. Form: SOLUTION/DROPS. Route: OPHTHALMIC
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIDOSE TR (TRAVOPROST) — FDA approvalJan 27, 2026 · 247d ago
- approvalIDOSE TR (TRAVOPROST) — FDA approvalJan 27, 2026 · 247d ago
- approvalTRAVATAN Z (TRAVOPROST) — FDA approvalOct 9, 2025 · 357d ago
- approvalIDOSE TR (TRAVOPROST) — FDA approvalDec 13, 2023 · 1023d ago
- approvalTRAVATAN Z (TRAVOPROST) — FDA approvalApr 2, 2020 · 2373d ago
- approvalTRAVATAN Z (TRAVOPROST) — FDA approvalSep 22, 2017 · 3296d ago
- approvalTRAVATAN Z (TRAVOPROST) — FDA approvalMar 11, 2016 · 3856d ago
- approvalTRAVATAN Z (TRAVOPROST) — FDA approvalSep 7, 2011 · 5503d ago
same company · ±60 days · 6
- approvalLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalDec 16, 2025
- approvalLOSARTAN POTASSIUM — FDA approvalDec 16, 2025
- approvalloteprednol etabonate: LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE) — FDA approvalDec 10, 2025
- recallAlembic Pharmaceuticals Limited recall (Cls III)Nov 26, 2025
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJan 14, 2026
- approvalropinirole hydrochloride ER: ROPINIROLE HYDROCHLORIDE — FDA approvalNov 19, 2025
comments(0)
5-min edit window · permanent after that